Skip Navigation


JAC Advance Access originally published online on May 12, 2005
Journal of Antimicrobial Chemotherapy 2005 56(1):250; doi:10.1093/jac/dki157
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/1/250    most recent
dki157v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ahmed, A. M.
Right arrow Articles by Shimamoto, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahmed, A. M.
Right arrow Articles by Shimamoto, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

Correspondence

Characterization of a multidrug-resistant isolate of Salmonella Paratyphi B from Japan

Ashraf M. Ahmed1, Kimi Furuta2, Kei Shimomura2, Hidekazu Kawamoto2 and Tadashi Shimamoto1,*

1 Laboratory of Food Microbiology and Hygiene, Graduate School of Biosphere Science, Hiroshima University, Higashi-Hiroshima 739-8528, Japan; 2 Division of Biological Science, Hiroshima City Institute of Public Health, Hiroshima 733-8650, Japan

*Corresponding author. Tel/Fax: +81-82-424-7897; Email: tadashis@hiroshima-u.ac.jp

Keywords: paratyphoid fever , Salmonella genomic island 1 (SGI1) , phage type DT 104

The first 10% of the full text of this article appears below.

Sir,

Enteric fever, comprising both typhoid and paratyphoid fevers, continues to be a global health problem with an estimated 12–33 million cases occurring worldwide each year.1 Paratyphoid fever is caused by Salmonella Paratyphi A, B and C and multidrug-resistance (MDR), defined as resistance to the three first-line agents chloramphenicol, ampicillin and co-trimoxazole, is an emerging problem in organisms of type . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
S. P. Djordjevic, A. K. Cain, N. J. Evershed, L. Falconer, R. S. Levings, D. Lightfoot, and R. M. Hall
Emergence and Evolution of Multiply Antibiotic-Resistant Salmonella enterica Serovar Paratyphi B D-Tartrate-Utilizing Strains Containing SGI1
Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2319 - 2326.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
A. M. Ahmed, A. I. A. Hussein, and T. Shimamoto
Proteus mirabilis clinical isolate harbouring a new variant of Salmonella genomic island 1 containing the multiple antibiotic resistance region
J. Antimicrob. Chemother., February 1, 2007; 59(2): 184 - 190.
[Abstract] [Full Text] [PDF]